Hartzel William 4
4 · Emergent BioSolutions Inc. · Filed May 1, 2026
Research Summary
AI-generated summary of this filing
Emergent BioSolutions SVP William Hartzel Receives RSU Award
What Happened William Hartzel, Senior Vice President, Bioservices at Emergent BioSolutions (EBS), was granted 100,111 restricted stock units (RSUs) reported as an acquisition on 2026-04-29. The filing shows an acquisition price of $0 (these were awarded, not purchased). The grant was approved by the Compensation Committee on March 2, 2026, and became effective after stockholder approval of the amended stock plan on April 29, 2026.
Key Details
- Transaction date and terms: 100,111 RSUs granted on 2026-04-29 at $0.00 per unit (award/grant, Form 4 code A).
- Vesting: RSUs vest in three annual installments beginning on the anniversary of the date of approval, subject to continued service (per filing footnotes).
- Each RSU equals the right to receive one share of Emergent common stock, subject to adjustment under the grant agreement.
- Shares owned after transaction: not specified in the provided filing excerpt.
- Filing timeliness: Form 4 filed 2026-05-01 for a 2026-04-29 report—no indication of a late filing in the document.
Context Restricted stock unit grants are a form of compensation that convert to actual shares only if and when they vest; they are common for executives and do not represent an open-market buy or sell. Because vesting is conditioned on continued service, these RSUs may not result in immediate share ownership or a market transaction.
Insider Transaction Report
- Award
Common Stock
[F1][F2]2026-04-29+100,111→ 187,299 total
Footnotes (2)
- [F1]The restricted stock unit grant was approved by the Compensation Committee of Emergent BioSolutions Inc. (the "Company"), on March 2, 2026, subject to stockholder approval of an amendment of the Company's 2006 Stock Incentive Plan (the "Amended Stock Incentive Plan"), under which the restricted stock units were granted. The Company's stockholders approved the Amended Stock Incentive Plan on April 29, 2026.
- [F2]Consists of restricted stock units granted under the Company's Amended Stock Incentive Plan. These restricted stock units vest in three annual installments beginning on the anniversary of the date of approval, assuming continued service with the Company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.